MAIA Biotechnology, Inc. (MAIA)
(Delayed Data from AMEX)
$3.31 USD
+0.03 (0.91%)
Updated May 6, 2024 04:00 PM ET
After-Market: $3.33 +0.02 (0.60%) 6:30 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
MAIA 3.31 +0.03(0.91%)
Will MAIA be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for MAIA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MAIA
MAIA Soars 20% on Interim Results From Lung Cancer Study
Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now
MAIA: What are Zacks experts saying now?
Zacks Private Portfolio Services
MAIA Biotechnology, Inc. (MAIA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
MAIA Biotechnology (MAIA) Up on Positive Data From NSCLC Study
Other News for MAIA
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
MAIA biotechnology announces share purchase by director in private placement
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement
MAIA Biotechnology announces share purchase by director Stan Smith in private placement
MAIA Biotechnology director purchases 147,492 shares in private placement